Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission

  • Gorin N
  • Labopin M
  • Blaise D
 et al. 
  • 14


    Mendeley users who have this article in their library.
  • 40


    Citations of this article.


The cell source for autologous stem cell transplantation has shifted from bone marrow (BM) to peripheral blood (PB). In acute myelocytic leukemia (AML), for patients who receive transplants during first complete remission (CR1), no prospective randomized study has compared relapse incidence (RI) to cell source.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Norbert Claude Gorin

  • Myriam Labopin

  • Didier Blaise

  • Josy Reiffers

  • Giovanna Meloni

  • Mauricette Michallet

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free